newsfilter
← Latest News
PR Newswire·

Seelos Therapeutics to Participate in the Guggenheim 4th Annual Immunology and Neurology Day

NEW YORK, Nov. 7, 2022 /PRNewswire/ -- Seelos Therapeutics, Inc. (NASDAQ:SEEL), a clinical-stage biopharmaceutical company focused on the development of therapies for central nervous system disorders and rare diseases,